Search
Lapatinib Action Pathway
smpdb.ca/view/SMP0126880Drug actionThis molecule is a tyrosine kinase inhibitor of the human epidermal growth factor receptor type 2 (HER2/ERBB2) and the epidermal growth factor receptor (HER1/EGFR/ERBB1). … Lapatinib is an anti-cancer drug used to treat advanced or metastatic breast cancer whose tumors overexpress the human epidermal receptor type 2 (HER2) protein and have received prior therapy.
Enzymes: Pro-epidermal growth factor, Epidermal growth factor receptorVEGF Signaling
smpdb.ca/view/SMP0524112SignalingVascular Endothelial Growth Factor (VEGF) is a critical protein that promotes angiogenesis, vascular permeability, and endothelial cell function. … MAPK (ERK1/2) and PKA-PKC pathways, regulating cell growth, survival, and migration.
Enzymes: Growth factor receptor-bound protein 2, Vascular endothelial growth factor AGefitinib Action Pathway (New)
smpdb.ca/view/SMP0122919Drug actionGefitinib is an epidermal growth factor receptor tyrosine kinase inhibitor used to treat tumors and certain cancers. … MAPK is activated through the epidermal growth factor receptor on the cell membrane and goes on to phosphorylate and regulate the activities of several transcription factors affecting cellular growth and
Enzymes: Pro-epidermal growth factor, Epidermal growth factor receptorTGF beta Signaling
smpdb.ca/view/SMP0524572SignalingJNK then activates ATF-2 and Jun, important transcription factors. Moreover, MKNK1 also activates Proto-oncogene c-Fos, a key transcription factor involved in cellular responses. … The TGF beta signaling pathway plays a role in regulating various cellular processes, including growth, differentiation, and immune responses.
Drugs: Magnesium cationEnzymes: Transcription factor Jun, Transforming growth factor beta-1Bemiparin Action Pathway
smpdb.ca/view/SMP0126156Drug actionThe mechanism of action of the antithrombotic acts mainly on factor Xa to prevent thromboembolism following surgery. … Some precautions is that Bemiparin may suppress the adrenal secretion of aldosterone and lead to elevated potassium.
Drugs: CalciumEnzymes: Coagulation factor XSulodexide Action Pathway
smpdb.ca/view/SMP0126173Drug actionDoing that also inhibits the conversion of fibrinogen to fibrin halting the clotting factor. Sulodexide is administered via oral, intravenous or intramuscular, it is mainly metabolized by the liver. … It is eliminated through renal, fecal and bile routes, and sometimes adverse effects occur that relate to the gastrointestinal system.
Drugs: CalciumEnzymes: Coagulation factor XReviparin Action Pathway
smpdb.ca/view/SMP0126278Drug actionReviparin is a low molecular weight heparin derived from a pig's intestinal mucus and used to prevent thromboembolism.
Enzymes: Coagulation factor XArdeparin Action Pathway (new)
smpdb.ca/view/SMP0126657Drug actionArdeparin acts on antithrombin III, which leads to the inactivation of factor Xa and thrombin inhibiting thrombosis. It is administered subcutaneously and travels to its target in the bloodstream. … Due to its anticoagulant nature herbs and supplements with similar activity should be avoided such as ginseng, ginkgo, ginger and garlic.
Enzymes: Coagulation factor XAxitinib Action Pathway
smpdb.ca/view/SMP0126901Drug actionIt belongs to the class of drugs known as tyrosine kinase inhibitors, specifically targeting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3). … Axitinib is recognized for its high potency compared to earlier VEGFR inhibitors and is available in oral formulations under the brand name Inlyta®.
Enzymes: Coagulation factor XCabozantinib Action Pathway
smpdb.ca/view/SMP0126903Drug actionCabozantinib's mechanism of action involves inhibiting various receptor tyrosine kinases, effectively suppressing processes such as metastasis, angiogenesis, and oncogenesis, making it a versatile therapeutic
Enzymes: Coagulation factor X